title: Extracorporeal membrane oxygenation is indicated for status asthmaticus refractory to maximal conventional therapy.
authors.forename: Taro
authors.initials: T
authors.lastname: Iwamoto
authors.forename: Kei
authors.initials: K
authors.lastname: Ikeda
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Nakajima
authors.forename: Masaki
authors.initials: M
authors.lastname: Suga
authors.forename: Kotaro
authors.initials: K
authors.lastname: Kumano
authors.forename: Masaki
authors.initials: M
authors.lastname: Hiraguri
authors.forename: Taro
authors.initials: T
authors.lastname: Imaeda
authors.forename: Daiki
authors.initials: D
authors.lastname: Harada
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Shiga
authors.forename: Reiko
authors.initials: R
authors.lastname: Oku
authors.forename: Kazuya
authors.initials: K
authors.lastname: Nakanishi
mesh_terms: D000328:Adult; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D015199:Extracorporeal Membrane Oxygenation; D006801:Humans; D008297:Male; D012121:Respiration, Artificial; D013224:Status Asthmaticus / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D018927:Anti-Asthmatic Agents